Fig. 2: PRISMA flowchart and overview of eligible literature.
From: Scoping review of preclinical and clinical studies on the role of HMGB1 in heart disease

a PRISMA flowchart showing the study selection process*. b Distribution of heart diseases covered in the included studies. c Categorisation of the literature based on study type and focus. *Created using an adaptation of a web-based tool (Haddaway et al., 2022 https://doi.org/10.1002/cl2.1230).